
Cardlytics (CDLX) Stock Forecast & Price Target
Cardlytics (CDLX) Analyst Ratings
Bulls say
Cardlytics Inc demonstrates a positive outlook due to anticipated improvements in fundamentals expected to manifest in the first quarter and continue throughout the year, driven by enhanced execution, contributions from new advertisers, and the successful launch of the American Express partnership. The company's fourth-quarter results exceeded expectations, marked by strong engagement with new advertisers and solid performance in the UK, indicating effective cost discipline and operational improvement. Additionally, the favorable balance sheet provides confidence in Cardlytics's ability to execute its turnaround strategy, suggesting potential for growth and margin enhancements moving into 2025 and beyond.
Bears say
Cardlytics Inc. faces a concerning outlook with projected revenue declines and significant challenges in achieving self-sustained growth, as indicated by anticipated billings of $91.5 million to $94.5 million in the first quarter, representing a year-over-year decrease of 10-13%. The company's fourth-quarter billings declined by 11.9% year-over-year, and expected revenue for the upcoming quarter is forecasted to drop by 11-16%, highlighting a persistent downward trend. Furthermore, the ongoing transition in business model alongside increased consumer redemptions is negatively impacting GAAP revenue, adjusted contribution dollars, EBITDA, and cash flow, contributing to a bearish financial perspective for the company.
This aggregate rating is based on analysts' research of Cardlytics and is not a guaranteed prediction by Public.com or investment advice.
Cardlytics (CDLX) Analyst Forecast & Price Prediction
Start investing in Cardlytics (CDLX)
Order type
Buy in
Order amount
Est. shares
0 shares